Mutations spark false negatives in COVID-19 testing

NCPA April 7, 2021

Mutations in the SARS-CoV-2 virus can potentially influence test performance and results. The FDA has identified several molecular tests affected by the mutations, including two tests authorized for the point-of-care setting. Learn more here.

NCPA